Peripheral Aneurysms

Background

Summary: Peripheral aneurysms of the lower extremities are uncommon, but popliteal artery aneurysms (PAA) are the most frequent true peripheral arterial aneurysm and are clinically important because their dominant complications are thrombosis and distal embolization leading to acute limb ischemia and chronic limb-threatening ischemia rather than rupture. (Dawson 1997) (Rutherford 2018) (Aboyans 2017)📄

In contrast to 4abdominal aortic aneurysm, where rupture risk drives many intervention thresholds, the management strategy for PAA prioritizes:

• Prevention of thromboembolism and limb loss through timely repair when indicated. (Aboyans 2017)📄 (ESVS 2020)
• Assessment and optimization of inflow/outflow ("runoff") because runoff strongly influences patency and limb outcomes after either open or endovascular repair. (Rutherford 2018) (Aboyans 2017)📄
• Recognition of systemic aneurysmal disease (frequent association with contralateral PAA and 4abdominal aortic aneurysm (AAA)), prompting structured screening and lifelong follow-up. (Dawson 1997) (Wanhainen 2019)📄 (Aboyans 2017)📄

Contemporary care should integrate guideline-based thresholds for elective repair, evidence-based perioperative cardiovascular risk reduction (antiplatelet therapy and high-intensity statin therapy), and a defined duplex ultrasound surveillance pathway for both unrepaired aneurysms and post-repair reconstructions. (Gerhard 2016)📄 (Heart Protection 2002) (Aboyans 2017)📄

Etiology and Risk Factors

• Atherosclerosis (most common). (Rutherford 2018)
• Connective tissue disorders (Marfan, Ehlers-Danlos, Loeys-Dietz).
• Trauma or iatrogenic injury.
• Infection (mycotic aneurysm, rare).
• Male sex, age >65, smoking, hypertension, family history of aneurysms. (Rutherford 2018)

Pathophysiology

• Progressive wall weakening → dilatation. (Rutherford 2018)
• Popliteal artery special risk: confined space behind knee → higher risk of thrombosis and compression. (Rutherford 2018)
• Thrombosis and embolism: mural thrombus forms, may occlude lumen or embolize distally. (Dawson 1997)
• Compression: nerve (neuropathy), vein (12VTE), or artery (claudication). (Rutherford 2018)

Clinical Presentation

• Asymptomatic: detected incidentally by imaging or physical exam (pulsatile mass).
• Symptomatic:
  • Claudication, rest pain.
  • Acute limb ischemia from thrombosis or embolization; (Dawson 1997) classified by 10Rutherford grade (Ch. 10).
  • Distal embolization → 'blue toe' syndrome, non-healing ulcers.
  • Rare: rupture (unlike abdominal aortic aneurysm (AAA)). (Dawson 1997)
  • Compression symptoms: deep vein thrombosis (DVT) may occur from popliteal vein compression—(Rutherford 2018) see 12Ch. 12 for management.

Physical exam: pulsatile mass in popliteal fossa; may be bilateral. (Dawson 1997)

Non-Invasive Assessment

Preferred initial test

• Duplex ultrasound (DUS) is first-line for diagnosis and surveillance because it defines aneurysm diameter, mural thrombus, and flow characteristics, and can assess inflow/outflow noninvasively. (Aboyans 2017)📄

What to document on DUS (recommended minimum dataset)

• Maximum aneurysm diameter (outer-to-outer wall). (Aboyans 2017)📄
• Presence and extent of mural thrombus (qualitative and, when feasible, circumferential burden). (Rutherford 2018)
• Inflow disease (SFA) and outflow/runoff (tibial vessels), including evidence of distal embolization. (Aboyans 2017)📄
• Baseline physiologic status using ankle-brachial index (ABI)/toe-brachial index (TBI) when ischemic symptoms or distal disease are suspected (see 10Ch. 10). (Aboyans 2012)📄 (Gerhard 2016)📄

Cross-sectional imaging for planning

• computed tomography angiography (CTA) is preferred for preoperative planning when repair is contemplated, particularly to map landing zones (endovascular), define calcification/tortuosity, and characterize tibial runoff. (Aboyans 2017)📄
• magnetic resonance angiography (MRA) is appropriate when iodinated contrast is contraindicated or to reduce radiation burden, acknowledging typical limitations in heavily calcified vessels. (Prince 2016) (Aboyans 2017)📄

Catheter angiography (DSA)

• Digital subtraction angiography (DSA) is reserved for intra-procedural guidance or when noninvasive imaging is discordant with clinical findings; it also enables simultaneous treatment of distal emboli or tibial lesions. (White 2006)📄 (Aboyans 2017)📄

Screening

Associated aneurysm screening in patients with PAA

Because PAA frequently clusters with other aneurysms, all patients diagnosed with a true PAA should undergo systematic screening for additional aneurysms using noninvasive imaging. (Dawson 1997) (Aboyans 2017)📄 (Wanhainen 2019)📄

Recommended screening targets and modalities

• Contralateral popliteal artery:

• DUS is preferred to confirm bilaterality, define size, and identify thrombus. (Dawson 1997) (Aboyans 2017)📄

• Abdominal aorta (abdominal aortic aneurysm (AAA) screening):

• Abdominal ultrasound is first-line screening. (Wanhainen 2019)📄
  • computed tomography angiography (CTA) is reserved for operative planning, equivocal ultrasound, or when cross-sectional imaging is already being obtained for lower-extremity planning. (Aboyans 2017)📄 (Wanhainen 2019)📄

• Femoral aneurysms (common femoral / superficial femoral):

• Consider targeted DUS or CTA review of the femoral segment given frequent multi-level aneurysmal disease. (Aboyans 2017)📄 (ESVS 2020)

Clinical implication

• Discovery of associated aneurysms alters surveillance burden and may change repair sequencing (for example, symptomatic/large AAA versus threatened limb from PAA). (Wanhainen 2019)📄 (Aboyans 2017)📄

Indications for repair

PAA repair indications (guideline-based framework)

Patient- and anatomy-specific modifiers (practical guidance)

• Vein conduit availability strongly influences open bypass durability; in good-risk patients with usable great saphenous vein, open repair is often favored for long-term patency. (Rutherford 2018) (Aboyans 2017)📄
• Endovascular suitability requires adequate proximal and distal landing zones and an understanding of knee-flexion dynamics across the popliteal segment. (Aboyans 2017)📄
• Runoff quality (tibial vessel patency) affects both open and endovascular outcomes and should be assessed explicitly during planning. (Aboyans 2017)📄 (Rutherford 2018)

Baseline medical therapy (applies to all PAA patients)

• Treat as systemic atherosclerotic disease: high-intensity statin therapy and antiplatelet therapy unless contraindicated. (Gerhard 2016)📄 (Heart Protection 2002)
• Smoking cessation counseling should be routine given adverse limb and survival outcomes in symptomatic peripheral arterial disease cohorts. (Armstrong 2014)

Open repair (gold standard)

Open repair (bypass with aneurysm exclusion)

Technique (common approach)

• Proximal and distal control with ligation/exclusion of the aneurysm.
• Bypass from superficial femoral artery (SFA) to distal popliteal (or tibial target when needed) with:
  • Autologous vein preferred (reversed or in situ great saphenous vein (GSV)). (Aboyans 2017)📄 (Rutherford 2018)
  • Prosthetic conduit reserved for selected patients when vein is unavailable, generally with inferior durability in below-knee targets. (Rutherford 2018)

Approach selection (practical)

• Medial approach facilitates longer bypasses and tibial targets when distal embolization/runoff disease is present. (Rutherford 2018)
• Posterior approach may be used for selected aneurysms confined to the popliteal fossa where direct aneurysm handling is required (for example, compressive symptoms), but is less flexible for tibial targets. (Rutherford 2018)

Outcomes and durability

• In elective settings with good conduit and runoff, open repair provides durable long-term patency and limb salvage, historically in the 70-90% 5-year range in surgical series. (Galland 2008)📄
• Presentation matters: acute thrombosis/embolization and poor runoff are associated with worse patency and higher reintervention risk. (Aboyans 2017)📄 (Rutherford 2018)
• Socioeconomic status (SES) also significantly impacts outcomes following revascularization for atherosclerotic peripheral arterial disease (PAD) and aneurysm repair, with lower SES associated with increased risks of adverse events and limb loss. (Zil 2024)

Antithrombotic therapy and risk reduction

• Long-term single antiplatelet therapy and statin therapy are generally recommended for atherosclerotic PAD risk reduction after infrainguinal bypass. (Gerhard 2016)📄 (Heart Protection 2002)
• Consideration of intensified antithrombotic strategies should be individualized based on bleeding risk and the type of reconstruction (see 10Ch. 10). (Eikelboom 2017)📄 (Bonaca 2020)📄

Postoperative surveillance

• Structured duplex surveillance improves detection of clinically significant graft stenosis and supports secondary patency. (Almasri 2018)📄 (Aboyans 2017)📄

Endovascular repair

Endovascular repair (covered stent-graft exclusion)

Covered stent-grafts can exclude a popliteal artery aneurysm (PAA) with lower early physiologic stress and shorter recovery in selected patients, but durability is sensitive to anatomy and knee-flexion biomechanics across the popliteal segment. (Aboyans 2017)📄 (Tielliu 2005) (Cassar 2005)📄 (Troisi 2025)

When to consider endovascular repair

• Elevated operative risk or limited life expectancy. (Aboyans 2017)📄
• No adequate autologous vein conduit. (Aboyans 2017)📄 (Rutherford 2018)
• Favorable anatomy:
  • Adequate proximal/distal landing zones. (Aboyans 2017)📄
  • Acceptable runoff, or a plan to address tibial disease/embolization when present. (Aboyans 2017)📄

Limitations and expected outcomes

• Compared with vein bypass, endovascular repair often has higher reintervention rates and inferior long-term primary patency in many series and reviews, emphasizing the need for careful patient selection and surveillance. (Huang 2007)📄 (Aboyans 2017)📄
• Early series commonly report ~60-70% primary patency at approximately 3 years, with secondary interventions improving limb outcomes; recent cohort data on self-expandable covered stents continue to support these findings in late-term follow-up. (Tielliu 2005) (Huang 2007)📄 (Troisi 2025)

Antithrombotic therapy (pragmatic)

• Antiplatelet therapy is generally used after lower-extremity endovascular interventions; dual-pathway inhibition (low-dose rivaroxaban plus aspirin) reduces major adverse limb events after revascularization in appropriate patients but must be balanced against bleeding risk. (Gerhard 2016)📄 (Bonaca 2020)📄

Surveillance requirement

• Endovascular PAA repair mandates more intensive duplex surveillance than elective open bypass because of edge stenosis, thrombosis risk, and potential deformation with knee flexion. (Aboyans 2017)📄 (Troisi 2025)

Hybrid approaches

• Hybrid approaches for the aortic arch typically involve extra-anatomical debranching (e.g., carotid-carotid or carotid-subclavian bypass) to create a proximal landing zone for thoracic endovascular aortic repair (TEVAR). (Rutherford 2018)
• While historically considered to have limited use, these techniques are increasingly employed for complex arch pathology, though standardized definitions of procedural success remain heterogeneous across clinical studies. (Rossi 2024)
• In the management of common carotid artery (CCA) disease, hybrid interventions—such as retrograde stenting combined with open surgical exposure or carotid endarterectomy—provide a versatile alternative to traditional open or purely endovascular techniques. (Snyder 2026)

Acute limb ischemia due to PAA thrombosis

Acute limb ischemia (ALI) from thrombosed/embolizing PAA

ALI from PAA is most commonly due to thrombosis or distal embolization from mural thrombus and requires urgent limb-focused management plus definitive aneurysm exclusion to prevent recurrence. (Rutherford 2018) (Aboyans 2017)📄

Initial actions (do not delay)

1. Immediate systemic anticoagulation with IV unfractionated heparin unless contraindicated. (Rutherford 2018)
2. Rapid clinical staging using Rutherford ALI categories (see 10Ch. 10). (Rutherford 2018)
3. Expedite imaging to guide therapy: DUS for rapid confirmation and inflow/outflow assessment, with computed tomography angiography (CTA) when procedural planning is needed. (Aboyans 2017)📄

Revascularization strategy (typical)

• Viable or marginally threatened limb (Rutherford I-IIa):

• Consider catheter-directed thrombolysis and/or adjunctive aspiration/mechanical thrombectomy to restore runoff, followed by definitive PAA repair (open bypass with exclusion in many cases; endovascular exclusion in selected anatomy/patients). (Aboyans 2017)📄 (Rutherford 2018) (Hsiao 2019)

• Immediately threatened limb (Rutherford IIb):

• Proceed directly to urgent open thrombectomy and bypass (often with tibial target) and aneurysm exclusion; thrombolysis is less favored due to time sensitivity. (Aboyans 2017)📄 (Rutherford 2018)

• Irreversible ischemia (Rutherford III):

• Revascularization is generally not appropriate; proceed with amputation planning and systemic stabilization (see 10Ch. 10). (Rutherford 2018)

Key principle

• Reperfusion alone is insufficient: the aneurysm must be excluded/treated to reduce recurrent embolization or rethrombosis. (Aboyans 2017)📄

Follow-up

PAA surveillance protocols (unrepaired and after repair)

Actionable surveillance findings (practical triggers)

• Hemodynamically significant graft stenosis on duplex (velocity criteria and waveform change) should prompt timely evaluation for revision to maintain patency. (Moneta 2010)📄 (Almasri 2018)📄
• After endovascular exclusion, new symptoms, reduced ABI/TBI, or duplex evidence of edge stenosis/thrombosis warrants expedited reintervention planning. (Aboyans 2017)📄 (Aboyans 2012)📄

Duration of follow-up

• Maintain lifelong surveillance, including contralateral popliteal and abdominal aortic screening/monitoring, due to frequent multi-aneurysm association. (Dawson 1997) (Wanhainen 2019)📄 (Aboyans 2017)📄

Tables

Table 5.1. Clinical Manifestations of Popliteal Aneurysms (Rutherford 2018)

Table 5.2. Open vs Endovascular PAA Repair (patient selection and expectations) (Aboyans 2017)📄 (ESVS 2020) (Huang 2007)📄

Table 5.3. Medical Therapy for PAA Patients (systemic risk reduction and post-revascularization) (Gerhard 2016)📄 (Heart Protection 2002) (CAPRIE 1996) (Bonaca 2020)📄 (Eikelboom 2017)📄

Natural history and risk stratification of asymptomatic popliteal artery aneurysms (PAA)

Asymptomatic popliteal artery aneurysms most often progress to thrombotic or embolic events rather than rupture. (Dawson 1997) Risk increases with larger diameter, intraluminal thrombus burden, and poor distal runoff. (Aboyans 2017)📄 Rupture is rare compared to abdominal aortic aneurysms. (Dawson 1997) These factors inform thresholds for elective repair and surveillance strategies.

Explicit evidence-based thresholds for elective repair (symptomatic vs asymptomatic)

Evidence-based thresholds guide the decision for elective repair. All symptomatic popliteal artery aneurysms should be repaired regardless of size. (Aboyans 2017)📄 For asymptomatic aneurysms, elective repair is generally recommended at ≥25 mm. (Aboyans 2017)📄 Earlier repair should be considered for aneurysms measuring 20–24 mm when accompanied by significant intraluminal thrombus, documented distal embolization, rapid growth, or compromised distal runoff. (Aboyans 2017)📄 Treatment decisions must be individualized based on patient risk profile and surgical candidacy.

Structured surveillance protocols (by aneurysm size and after repair)

Surveillance protocols should be tailored to aneurysm size, thrombus burden, and treatment modality. For unrepaired popliteal artery aneurysms measuring <20–25 mm without thrombus, duplex ultrasound surveillance is recommended every 6–12 months. The surveillance interval should be shortened if thrombus develops, growth is documented, or symptoms arise. (Aboyans 2017)📄 After open bypass, duplex ultrasound is recommended at 1, 6, and 12 months, then annually thereafter. (Aboyans 2017)📄 After endovascular repair, more intensive surveillance is warranted with duplex ultrasound at 1, 3, 6, and 12 months, followed by every 6–12 months long-term, with particular attention to stent-graft compression or kinking during knee flexion. (Aboyans 2017)📄

Comparative outcomes: open vs endovascular repair with patient selection

Open bypass with autologous vein conduit remains the gold standard for durability, particularly in good-risk surgical candidates with adequate vein and distal runoff. (Huang 2007)📄 Long-term patency rates of 70–90% at 5 years have been consistently reported with vein bypass. (Galland 2008)📄 Endovascular repair with covered stent grafts offers advantages of lower perioperative morbidity and shorter hospital length of stay, (Cassar 2005)📄 making it attractive for high-risk patients or those lacking suitable vein conduit. However, endovascular repair is associated with higher reintervention rates and inferior long-term patency compared to open bypass, (Huang 2007)📄 particularly in the challenging environment across the knee joint. Anatomic suitability requires adequate proximal and distal landing zones and careful consideration of stent-graft deformation dynamics with knee flexion. Reported primary patency at 3 years commonly ranges from 60–70% in early series, (Tielliu 2005) with secondary interventions improving overall limb salvage rates.

Associated aneurysm screening beyond AAA (contralateral popliteal and femoral aneurysms) with modality

The high frequency of multiple aneurysms in patients with popliteal artery aneurysms mandates systematic screening. Contralateral popliteal artery imaging should be performed in all patients, with duplex ultrasound as the preferred modality. (Dawson 1997) Up to 50% of patients will have bilateral popliteal aneurysms. (Dawson 1997) Screening for 4abdominal aortic aneurysm is essential, as the association occurs in up to 40% of cases; (Dawson 1997) abdominal ultrasound is the recommended first-line imaging modality, with computed tomography angiography reserved for operative planning or when ultrasound findings are equivocal. Assessment for concomitant femoral artery aneurysms should also be considered given the frequent clustering of peripheral aneurysms in affected individuals. (Aboyans 2017)📄